Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Asset disposition
Acq. announced
Director departure
MEI Pharma, Inc. (MEIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/13/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2023 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
10/10/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
10/10/2023 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
10/03/2023 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
10/03/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "Certificate of Designation of Series A Junior Participating Preferred Stock of MEI Pharma, Inc",
"Rights Agreement, by and between MEI Pharma, Inc. and Computershare, Inc., as rights agent",
"MEI Pharma Adopts Limited-Duration Stockholder Rights Plan"
10/02/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/02/2023 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
09/29/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
09/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/28/2023 PRER14A Form PRER14A - Preliminary Proxy Soliciting materials:
09/26/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
09/26/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/26/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights"
09/26/2023 10-K Annual Report for the period ended June 30, 2023
09/26/2023 DEFC14A Form DEFC14A - Definitive proxy statement, contested solicitations:
08/08/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/04/2023 PRRN14A Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
08/01/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation and Release Agreement between the Company and Brian Drazba",
"Separation and Release Agreement between the Company and Brian Drazba"
07/24/2023 8-K Quarterly results
07/19/2023 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
07/19/2023 425 Form 425 - Prospectuses and communications, business combinations:
07/19/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy